Value of Syntara, page-74

  1. 1,158 Posts.
    lightbulb Created with Sketch. 2649
    Hi all,

    Just to clarify where we are up to on keloid and hypertrophic scarring.

    The Company has reformulated the product into SNT 9465 a next generation pan lox inhibitor.

    Below is the last trial results which indicated a new version was required. I believe what Professor Wood says about the new version, it's a paradigm shift compared to SNT 6302. Trials to start soon.

    https://www.medrxiv.org/content/10.1101/2025.02.12.25321764v1

    Kpax


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.7¢
Change
-0.010(14.9%)
Mkt cap ! $92.60M
Open High Low Value Volume
6.7¢ 6.7¢ 5.5¢ $569.7K 9.664M

Buyers (Bids)

No. Vol. Price($)
1 5000 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 468564 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.